SURUNKALI BUYRAK KASALLIGINING TURLI BOSQICHLARIDA KLINIK BELGILARNING O’ZIGA XOSLIGI
;
https://doi.org/10.5281/zenodo.20284839;
surunkali buyrak kasalligi, klinik bosqichlar, eGFR, proteinuriya, arterial gipertenziya, uremiya, nefrologiyaAbstrak
Surunkali buyrak kasalligi (SBK) buyrak funksiyasining uzoq muddat davomida progressiv pasayishi va buyrak to‘qimalarining qaytmas strukturaviy shikastlanishi bilan tavsiflanadigan surunkali patologik holat hisoblanadi [1,2]. So‘nggi yillarda SBK dunyo miqyosida keng tarqalgan kasalliklardan biriga aylanib, sog‘liqni saqlash tizimi oldidagi muhim muammolardan biri sifatida e’tirof etilmoqda. Kasallikning yuqori tarqalganligi, nogironlikka olib kelishi hamda yurak-qon tomir asoratlari va o‘lim xavfini oshirishi uning klinik ahamiyatini yanada kuchaytiradi [3]. Jahon statistik ma’lumotlariga ko‘ra, katta yoshdagi aholining sezilarli qismida turli darajadagi SBK uchraydi va ushbu ko‘rsatkich yil sayin ortib bormoqda.Iqtiboslar
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266.
Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline. Kidney International Supplements. 2013;3(1):5–14.
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3(4):368–371.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management. JAMA. 2019;322(13):1294–1304.
##submission.downloads##
Nashr qilingan
Nashr
Bo'lim
Litsenziya
##submission.copyrightStatement##
##submission.license.cc.by4.footer##Iqtibos keltirish tartibi
